KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Overview Fund Activity
Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

289 hedge funds and large institutions have $8.16B invested in Karuna Therapeutics, Inc. Common Stock in 2023 Q2 according to their latest regulatory filings, with 72 funds opening new positions, 92 increasing their positions, 90 reducing their positions, and 29 closing their positions.

Holders
289
Holders Change
+43
Holders Change %
+17.48%
% of All Funds
4.56%
Holding in Top 10
10
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
72
Increased
92
Reduced
90
Closed
29
Calls
$207M
Puts
$111M
Net Calls
+$96.4M
Net Calls Change
+$1.28M

Top Buyers

1
Capital International Investors
1
Capital International Investors
California
$866M
2
PBA
2
Paradigm Biocapital Advisors
New York
$61.5M
3
BC
3
Boxer Capital
California
$54.2M
4
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$577M
5
Millennium Management
5
Millennium Management
New York
$33.5M

Top Sellers

1
BlackRock
1
BlackRock
New York
$404M
2
Viking Global Investors
2
Viking Global Investors
Connecticut
$206M
3
Point72 Asset Management
3
Point72 Asset Management
Connecticut
$9.96M
4
SI
4
Sofinnova Investments
California
$300M
5
AllianceBernstein
5
AllianceBernstein
Tennessee
$83.3M
Name Market Value Shares Shares
Change 		Shares
Change %
Fidelity Investments
1
Fidelity Investments
Massachusetts
$1.22B 5,616,588 +10,502 +0.2%
Capital International Investors
2
Capital International Investors
California
$866M 3,992,549 +602,942 +18%
Vanguard Group
3
Vanguard Group
Pennsylvania
$672M 3,097,899 +78,353 +3%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$577M 2,661,492 +179,932 +7%
T. Rowe Price Investment Management
5
T. Rowe Price Investment Management
Maryland
$538M 2,479,035 -1,730 -0.1%
BlackRock
6
BlackRock
New York
$404M 1,864,636 -605,163 -25%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$304M 1,400,237 -206,617 -13%
SI
8
Sofinnova Investments
California
$300M 1,381,149 -391,975 -22%
Viking Global Investors
9
Viking Global Investors
Connecticut
$206M 947,955 -553,119 -37%
State Street
10
State Street
Massachusetts
$177M 815,286 -181,249 -18%
PBPIA
11
Pivotal bioVenture Partners Investment Advisor
California
$170M 782,008 – –
GA
12
General Atlantic
New York
$158M 726,958 +10,800 +2%
Lord, Abbett & Co
13
Lord, Abbett & Co
New Jersey
$125M 574,606 +83,464 +17%
RSCM
14
Rock Springs Capital Management
Maryland
$107M 493,527 – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$105M 484,147 -118,288 -20%
APM
16
Avidity Partners Management
Texas
$95.9M 442,200 +38,400 +10%
Invesco
17
Invesco
Georgia
$85.8M 395,557 +62,602 +19%
AllianceBernstein
18
AllianceBernstein
Tennessee
$83.3M 383,962 -242,228 -39%
EAM
19
Eventide Asset Management
Massachusetts
$73.7M 339,968 +70 +0%
Brown Advisory
20
Brown Advisory
Maryland
$70.1M 323,458 +397 +0.1%
PBA
21
Paradigm Biocapital Advisors
New York
$61.5M 283,605 +283,605 New
Norges Bank
22
Norges Bank
Norway
$60M 276,711 -69,233 -20%
BC
23
Boxer Capital
California
$54.2M 250,000 +250,000 New
Fiera Capital (Canada)
24
Fiera Capital (Canada)
Quebec, Canada
$50.5M 232,760 -5,418 -2%
NFGH
25
Nan Fung Group Holdings
Hong Kong
$48.9M 225,688 – –
1
2 3 4 5